论文信息 - NAN-190: an arylpiperazine analog that antagonizes the stimulus effects of the 5-HT1A agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT). - 字舞流文

NAN-190: an arylpiperazine analog that antagonizes the stimulus effects of the 5-HT1A agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT).

In order to determine whether NAN 190 might serve as a 5-HT 1A antagonist, it was evaluated in rats trained to discriminate 8-OH-DPAT HBr from saline in a 2-lever operant procedure

R. Glennon | M. Titeler | R. A. Lyon | M. E. Pierson | R A Glennon | N A Naiman | M E Pierson | M Titeler | R A Lyon | E Weisberg | N. Naiman | E. Weisberg

[1] R. Glennon,et al. Arylpiperazine derivatives as high-affinity 5-HT1A serotonin ligands. , 1988, Journal of medicinal chemistry.

[2] R. Glennon,et al. Stimulus generalization of 1-(3-trifluoromethylphenyl)piperazine (TFMPP) to propranolol, pindolol and mesulergine , 1988, Pharmacology Biochemistry and Behavior.

[3] R. Glennon. Discriminative stimulus properties of the 5-HT1A agonist 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH DPAT) , 1986, Pharmacology Biochemistry and Behavior.

[4] J. Neill,et al. Mediation of the discriminative stimulus properties of 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) by the putative 5-HT1A receptor. , 1987, European journal of pharmacology.